- Home
- VTEX vs CRMD Comparison
VTEX vs CRMD Comparison
Compare VTEX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTEX
- CRMD
- Stock Information
- Founded
- VTEX 1999
- CRMD 2006
- Country
- VTEX Cayman Islands
- CRMD United States
- Employees
- VTEX N/A
- CRMD N/A
- Industry
- VTEX Computer Software: Prepackaged Software
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- VTEX Technology
- CRMD Health Care
- Exchange
- VTEX Nasdaq
- CRMD Nasdaq
- Market Cap
- VTEX 757.0M
- CRMD 865.2M
- IPO Year
- VTEX 2021
- CRMD 2010
- Fundamental
- Price
- VTEX $4.21
- CRMD $10.50
- Analyst Decision
- VTEX Strong Buy
- CRMD Strong Buy
- Analyst Count
- VTEX 4
- CRMD 8
- Target Price
- VTEX $7.63
- CRMD $17.57
- AVG Volume (30 Days)
- VTEX 1.1M
- CRMD 2.6M
- Earning Date
- VTEX 11-04-2025
- CRMD 10-29-2025
- Dividend Yield
- VTEX N/A
- CRMD N/A
- EPS Growth
- VTEX 48.79
- CRMD N/A
- EPS
- VTEX 0.05
- CRMD 0.79
- Revenue
- VTEX $230,497,000.00
- CRMD $121,484,498.00
- Revenue This Year
- VTEX $10.08
- CRMD $480.51
- Revenue Next Year
- VTEX $14.18
- CRMD $59.81
- P/E Ratio
- VTEX $79.79
- CRMD $13.56
- Revenue Growth
- VTEX 4.53
- CRMD 14970.29
- 52 Week Low
- VTEX $3.92
- CRMD $5.60
- 52 Week High
- VTEX $7.31
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- VTEX 40.77
- CRMD 36.54
- Support Level
- VTEX $4.27
- CRMD $11.05
- Resistance Level
- VTEX $4.62
- CRMD $11.71
- Average True Range (ATR)
- VTEX 0.15
- CRMD 0.47
- MACD
- VTEX 0.01
- CRMD -0.04
- Stochastic Oscillator
- VTEX 6.82
- CRMD 5.29
About VTEX VTEX
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.